sec filing
OV
NASDAQ · OVID
Ovid Therapeutics Inc.
Healthcare · Biotechnology
$2.37
Up+$0.03 (+1.28%)
Updated Oct 7, 2026, 4:29 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 117.35M
- P/E ratio
- -0.06
- Dividend yield
- 0.00%
- 52-week range
- $1.18 – $3.11
- Volume
- 1.74M
- Avg. volume
- 2.89M
Price performance · OVID
OVID price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
OVID closed at $2.37 after 21 trading sessions, down 13.82% for the selected period.
- Last close
- $2.37
- Period change
- -13.82%
- Period low
- $2.34
- Period high
- $2.76
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $2.42 | $2.44 | $2.27 | $2.37 | 1.74M |
| Oct 5, 2026 | $2.38 | $2.47 | $2.29 | $2.34 | 1.2M |
| Oct 2, 2026 | $2.47 | $2.48 | $2.33 | $2.38 | 2.17M |
| Oct 1, 2026 | $2.49 | $2.53 | $2.42 | $2.43 | 1.35M |
| Sep 30, 2026 | $2.54 | $2.605 | $2.48 | $2.49 | 1.44M |
| Sep 29, 2026 | $2.47 | $2.54 | $2.42 | $2.54 | 1.16M |
| Sep 28, 2026 | $2.40 | $2.49 | $2.35 | $2.46 | 1.19M |
| Sep 25, 2026 | $2.49 | $2.51 | $2.40 | $2.40 | 1.36M |
| Sep 24, 2026 | $2.54 | $2.54 | $2.405 | $2.495 | 1.53M |
| Sep 23, 2026 | $2.75 | $2.75 | $2.44 | $2.57 | 2.64M |
| Sep 22, 2026 | $2.76 | $2.845 | $2.714 | $2.76 | 3.74M |
| Sep 21, 2026 | $2.73 | $2.76 | $2.65 | $2.71 | 1.18M |
| Sep 18, 2026 | $2.68 | $2.73 | $2.63 | $2.69 | 5.9M |
| Sep 17, 2026 | $2.73 | $2.77 | $2.66 | $2.70 | 1.99M |
| Sep 16, 2026 | $2.72 | $2.765 | $2.65 | $2.68 | 1.43M |
| Sep 15, 2026 | $2.73 | $2.745 | $2.63 | $2.71 | 988.55K |
| Sep 14, 2026 | $2.755 | $2.795 | $2.6901 | $2.74 | 1.2M |
| Sep 11, 2026 | $2.73 | $2.73 | $2.64 | $2.69 | 1.15M |
| Sep 10, 2026 | $2.68 | $2.70 | $2.61 | $2.63 | 1.4M |
| Sep 9, 2026 | $2.74 | $2.781 | $2.685 | $2.70 | 1.26M |
| Sep 8, 2026 | $2.75 | $2.81 | $2.73 | $2.75 | 1.15M |
Latest OVID news
The latest Smart Investors Daily articles mentioning OVID.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

